Shanghai Haohai Biological reports H-share repurchases

Shanghai Haohai Biological Technology Co. Ltd. disclosed share movements for its H-shares and A-shares in a filing dated December 22, 2025. The company's H-share capital remained at 38,529,240, with no change in issued shares or treasury shares as of December 22, 2025. The company had previously repurchased 17,000 H-shares on December 22, 2025, at a weighted average price of HK$25.58, totaling HK$434,916.

The company's A-share capital remained at 190,203,760 issued shares and 3,848,095 treasury shares. These figures indicate no change in A-share issued or treasury stock as of December 22, 2025.

The total ordinary shares of the company, including both A and H shares, amount to 228,733,000.